Drug Trial Radar · NCT06865105
Study of Targeted Therapies for the Treatment of Adult Participants With Active Psoriatic Arthritis
Last checked: Nov 19, 2026Latest source record: Nov 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
300
Planned (sponsor's estimate)
Start
Apr 11, 2025
Primary completion
Aug 2029
Study completion Aug 2029
Sponsor
- Lead sponsor
- AbbVieAbbVie (ABBV)
- Sponsor type
- Industry
- First posted
- Mar 7, 2025
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Psoriatic arthritis (PsA) is a type of arthritis that happens when the body's immune system attacks healthy cells and tissues causing joint pain, stiffness, and swelling. Symptoms can get worse and go away for periods of time. This study will evaluate the efficacy and safety of targeted therapies through a series of substudies, for the treatment of active psoriatic arthritis and to assess the changes in disease symptoms. The therapies being assessed in this study are risankizumab, lutikizumab, ABBV-701, and ABBV-547. In Substudy 1, participants will be randomized in a 1:1:1 ratio to one of the three treatment arms: lutikizumab monotherapy, risankizumab monotherapy or a combination therapy of lutikizumab and risankizumab. In Substudy 2, participants will be randomized in a 1:1:1 ratio to one of the three treatment arms: ABBV-701 monotherapy, risankizumab monotherapy, or a combination therapy of ABBV-701 and risankizumab. In Substudy 3, participants will be randomized in a 1:1:1 ratio to one of three doses of ABBV-547. Around 300 participants will be enrolled in the study at approximately 110 sites worldwide.
Conditions
- Psoriatic Arthritis
Interventions
LutikizumabDrug
Subcutaneous (SC) Injection
RisankizumabDrug
Subcutaneous (SC) Injection
ABBV-701Drug
Subcutaneous (SC) Injection
ABBV-547Drug
Subcutaneous (SC) Injection
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Participants With an American College of Rheumatology 50% (ACR50) ResponseTime frame: At Week 16
- Number of Participants With Adverse Events (AEs)Time frame: Up to Week 52
Locations
41 sites in 6 countries. Site status is shown where the registry gives one.
Newport Huntington Medical Group /ID# 272764
Huntington Beach, California · Recruiting
Highlands Advanced Rheumatology And Arthritis Center - Avon Park /ID# 273085
Avon Park, Florida · Recruiting
Clinical Research Of West Florida - Phase I Unit /ID# 273198
Clearwater, Florida · Recruiting
HMD Research LLC /ID# 273086
Orlando, Florida · Recruiting
West Broward Rheumatology Associates /ID# 272892
Tamarac, Florida · Recruiting
Clinical Research Of West Florida - Tampa - North Howard Avenue /ID# 273199
Tampa, Florida · Recruiting
Northwestern Medicine - Northwestern Memorial Hospital /ID# 275469
Chicago, Illinois · Recruiting
Clinic Of Dr. Robert Hozman/Clinical Investigation Specialists, Inc /ID# 272879
Skokie, Illinois · Completed
Willow Rheumatology and Wellness /ID# 277354
Willowbrook, Illinois · Recruiting
Klein & Associates /ID# 272829
Cumberland, Maryland · Completed
Dartmouth-Hitchcock Medical Center /ID# 272702
Lebanon, New Hampshire · Recruiting
Paramount Medical Research and Consulting /ID# 272757
Middleburg Heights, Ohio · Recruiting
Altoona Center For Clinical Research /ID# 272593
Duncansville, Pennsylvania · Recruiting
Private Practice - Dr. Ramesh C. Gupta /ID# 272897
Memphis, Tennessee · Recruiting
Tekton Research - West Gate /ID# 272765
Austin, Texas · Recruiting
Arthritis and Rheumatology Research Institute - Frisco /ID# 277306
Frisco, Texas · Recruiting
Accurate Clinical Research - Houston /ID# 272754
Houston, Texas · Recruiting
Tekton Research, LLC /ID# 272901
San Antonio, Texas · Recruiting
DM Clinical Research - Tomball /ID# 272760
Tomball, Texas · Recruiting
Centre Hospitalier Universite De Sherbrooke - Hotel-Dieu Hospital /ID# 273715
Sherbrooke, Quebec, Canada · Recruiting
Centre de Recherche Musculo-Squelettique /ID# 274397
Trois-Rivières, Quebec, Canada · Recruiting
Dr. Latha Naik Medical Professional Corporation /ID# 272803
Saskatoon, Saskatchewan, Canada · Recruiting
Medical Plus Research /ID# 272363
Uherské Hradiště, Czechia · Recruiting
PV Medical Services /ID# 272368
Zlín, Czechia · Recruiting
Revmatologie /ID# 272367
Brno, Brno-mesto, Czechia · Recruiting
L.K.N. Arthrocentrum /ID# 272366
Hlučín, Moravian-Silesian Region, Czechia · Recruiting
Centre Hospitalier Universitaire de Nice - Hopital Pasteur /ID# 272771
Nice, Alpes-Maritimes, France · Recruiting
Infirmerie Protestante De Lyon /ID# 273731
Caluire-et-Cuire, Auvergne-Rhône-Alpes, France · Recruiting
Centre Hospitalier Regional Universitaire De Tours - Hopital Trousseau /ID# 272762
Chambray-lès-Tours, Indre-et-Loire, France · Recruiting
Centre Hospitalier Regional d Orleans - Hopital de la Source /ID# 272877
Orléans, Loiret, France · Completed
Chu Bordeaux - Hopital Pellegrin /ID# 273390
Bordeaux, New Aquitaine, France · Completed
Semmelweis Egyetem Reumatologiai es Immunologiai Klinika /ID# 273195
Budapest, Hungary · Recruiting
Revita Reumatologiai Rendelo (Revita Kft.) /ID# 272857
Budapest, Hungary · Recruiting
Borsod-Abauj-Zemplen Varmegyei Kozponti Korhaz es Egyetemi Oktatokorhaz /ID# 272572
Miskolc, Borsod-Abauj Zemplen county, Hungary · Recruiting
Complex Rendelo Med Zrt. /ID# 272570
Székesfehérvár, Fejér, Hungary · Recruiting
Vital-Medicina /ID# 272855
Veszprém, Fejér, Hungary · Recruiting
Medicover Integrated Clinical Services - Bydgoszcz (SMO/Network/Consortium) /ID# 273297
Bydgoszcz, Kuyavian-Pomeranian Voivodeship, Poland · Recruiting
MCBK S.C. Iwona Czajkowska Anna Podrazka-Szczepaniak /ID# 273305
Pruszków, Masovian Voivodeship, Poland · Recruiting
Centrum Medyczne Reuma Park /ID# 273301
Warsaw, Masovian Voivodeship, Poland · Recruiting
Osteo Medic s.c. Artur Racewicz Jerzy Supronik /ID# 273304
Bialystok, Podlaskie Voivodeship, Poland · Completed
Showing 40 of 41 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.